The assessment of disease outcome among patients with juvenile rheumatoid arthritis (JRA) has been hampered by the lack of validated, sensitive instruments for the measurement of functional ability. Existing studies express outcome only in terms of process variables (number of joints with swelling, etc.), broad functional status categories (Steinbrocker class), or whether roentgenographic evidence of joint destruction has occurred. The goals of the project are: (1) to describe disease outcome, expressed as functional ability and chronicity, in a large cohort of patients who have had JRA for a minimum of 5 years, and (2) to provide preliminary data and feasibility information for a future project entitled, """"""""Predictors of Disease Outcome in JRA."""""""" The specific aim is to generate a """"""""status report"""""""" on the outcome of JRA, expressed as functional ability and chronicity, based in the 1990's. Patients who have had JRA 5 years or longer will be identified by searching the computerized databank of the Special Treatment Center for Juvenile Arthritis at Children's Hospital Medical Center, Cincinnati. A standardized, well validated methodology for conducting disease outcome studies developed at Stanford University will be used for contacting potential subjects and obtaining the appropriate data. Patients or their parents (estimated sample size is 400+) will be asked to complete either the newly available Childhood Health Assessment Questionnaire or, depending upon age, the Health Assessment Questionnaire. Information obtained will be condensed into a """"""""status report"""""""" on the outcome of JRA based in the 1990's. Long-term objectives and potential benefits include the following: 1. Future studies of disease outcome may use information from this project as reference data to measure: (1) change in the long-term outcome of JRA, and (2) the impact of new therapies now being developed. 2. The current project will provide preliminary data and feasibility information for a future study, to be submitted as an R01 application entitled, """"""""Predictors of Disease Outcome in JRA.""""""""

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Thornton, Sherry; Sowders, Dawn; Aronow, Bruce et al. (2002) DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 105:155-68
Scola, Michael P; Thompson, Susan D; Brunner, Hermine I et al. (2002) Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 29:369-78
Thornton, S; Kuhn, K A; Finkelman, F D et al. (2001) NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2. Eur J Immunol 31:3355-60
Griffin, T A; Slack, J P; McCluskey, T S et al. (2000) Identification of proteassemblin, a mammalian homologue of the yeast protein, Ump1p, that is required for normal proteasome assembly. Mol Cell Biol Res Commun 3:212-7
Thornton, S; Boivin, G P; Kim, K N et al. (2000) Heterogeneous effects of IL-2 on collagen-induced arthritis. J Immunol 165:1557-63
Lovell, D J; Giannini, E H; Reiff, A et al. (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763-9
Hashkes, P J; Balistreri, W F; Bove, K E et al. (1999) The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 134:47-52
Lovell, D J; Lindsley, C B; Rennebohm, R M et al. (1999) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis D Arthritis Rheum 42:2213-9
Murray, K J; Grom, A A; Thompson, S D et al. (1998) Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 25:1388-98
Sleight, B J; Prasad, V S; DeLaat, C et al. (1998) Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant 22:375-80

Showing the most recent 10 out of 32 publications